These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26756048)

  • 1. An initiative to extend testing for familial hypercholesterolaemia across the U.K.
    Nicholls M
    Eur Heart J; 2015 Oct; 36(39):2627-8. PubMed ID: 26756048
    [No Abstract]   [Full Text] [Related]  

  • 2. Results from a family and DNA based active identification programme for familial hypercholesterolaemia.
    ten Asbroek AH; de Mheen PJ; Defesche JC; Kastelein JJ; Gunning-Schepers LJ
    J Epidemiol Community Health; 2001 Jul; 55(7):500-2. PubMed ID: 11413180
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial hypercholesterolaemia--screening is effective, but is it cost effective?
    Fox KF
    Eur Heart J; 2002 Dec; 23(24):1892-3. PubMed ID: 12473248
    [No Abstract]   [Full Text] [Related]  

  • 4. People at risk of familial hypercholesterolaemia should have DNA test, says NICE.
    BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attitude to genetic screening for familial hypercholesterolemia].
    Ose L; Vollebaek LE; Tonstad S
    Tidsskr Nor Laegeforen; 1998 Apr; 118(10):1578-81. PubMed ID: 9615587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolaemia: A global call to arms.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK
    Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930
    [No Abstract]   [Full Text] [Related]  

  • 7. Universal screening of children for familial hypercholesterolaemia: Value for money?
    Ademi Z; Martin AC
    Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial hypercholesterolaemia: a look back, a look ahead.
    Burnett JR; Ravine D; van Bockxmeer FM; Watts GF
    Med J Aust; 2005 Jun; 182(11):552-3. PubMed ID: 15938678
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
    Page MM; Stefanutti C; Sniderman A; Watts GF
    Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LDLR variant T705I does not cause the typical phenotype of familial hypercholesterolaemia.
    Graham CA; Wright WT; McIlhatton BP; Young IS; Nicholls DP
    Atherosclerosis; 2006 Sep; 188(1):218-9. PubMed ID: 16735037
    [No Abstract]   [Full Text] [Related]  

  • 11. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837
    [No Abstract]   [Full Text] [Related]  

  • 12. PGD and familial hypercholesterolaemia.
    Reprod Biomed Online; 2008 Feb; 16(2):307. PubMed ID: 18284891
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the yield of genetic testing in familial hypercholesterolaemia.
    Ajufo E; Cuchel M
    Eur Heart J; 2017 Feb; 38(8):574-576. PubMed ID: 27161618
    [No Abstract]   [Full Text] [Related]  

  • 14. Decision to reject screening for familial hypercholesterolaemia is flawed.
    Wald DS; Martin AC
    Arch Dis Child; 2021 Jun; 106(6):525-526. PubMed ID: 32601084
    [No Abstract]   [Full Text] [Related]  

  • 15. The UK National Screening Committee's position on child-parent screening for familial hypercholesterolaemia.
    Wald DS; Neely D
    J Med Screen; 2021 Sep; 28(3):217-220. PubMed ID: 34292841
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular epidemiology of familial hypercholesterolaemia.
    Defesche JC; Kastelein JJ
    Lancet; 1998 Nov; 352(9141):1643-4. PubMed ID: 9853432
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic unexceptionalism: clinician accounts of genetic testing for familial hypercholesterolaemia.
    Will CM; Armstrong D; Marteau TM
    Soc Sci Med; 2010 Sep; 71(5):910-7. PubMed ID: 20591544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective.
    Laurie AD; Scott RS; George PM
    Atheroscler Suppl; 2004 Dec; 5(5):13-5. PubMed ID: 15556094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolaemia.
    Vohnout B; Raslová K; Gasparovic J; Donati MB; Iacoviello L
    Lancet; 2001 May; 357(9269):1712. PubMed ID: 11428370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.